Kala Pharmaceuticals Inc. (KALA)
8.73
-0.04 (-0.46%)
At close: Jan 29, 2025, 3:58 PM
8.83
1.15%
After-hours Jan 29, 2025, 03:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -42.20M | -44.82M | -142.60M | -104.33M | -94.35M | -66.74M | -42.21M | -33.17M | -16.68M | -19.36M | -10.65M |
| Depreciation & Amortization | 303.00K | 537.00K | 975.00K | 912.00K | 843.00K | 955.00K | 287.00K | 297.00K | 330.00K | 298.00K | 201.00K |
| Stock-Based Compensation | 7.46M | 7.01M | 16.09M | 13.31M | 9.99M | 8.62M | 3.57M | 2.07M | 638.00K | n/a | n/a |
| Other Working Capital | 3.18M | -14.28M | -1.83M | -2.24M | 6.67M | 160.02M | 2.10M | 2.02M | -36.00K | 1.83M | 156.00K |
| Other Non-Cash Items | -2.39M | -42.12M | 22.51M | 2.99M | 2.73M | 274.00K | 111.00K | 106.00K | 134.00K | 1.54M | -277.00K |
| Deferred Income Tax | n/a | n/a | 5.42M | -5.00K | n/a | 390.00K | 1.84M | 1.67M | 151.00K | n/a | n/a |
| Change in Working Capital | 8.89M | 491.00K | -10.62M | -3.57M | -11.94M | 2.38M | 2.30M | 1.68M | 340.00K | 2.17M | -113.00K |
| Operating Cash Flow | -27.93M | -78.91M | -108.23M | -90.69M | -92.72M | -54.12M | -34.10M | -27.35M | -15.09M | -15.36M | -10.84M |
| Capital Expenditures | -610.00K | -313.00K | -886.00K | -1.94M | -1.33M | -1.58M | -480.00K | -153.00K | -252.00K | -225.00K | -789.00K |
| Acquisitions | n/a | 62.91M | -4.65M | 2.07M | n/a | n/a | n/a | n/a | n/a | 3.00K | n/a |
| Purchase of Investments | -9.87M | -4.99M | n/a | -113.59M | n/a | n/a | n/a | n/a | n/a | n/a | -52.00K |
| Sales Maturities Of Investments | 10.00M | 5.00M | 76.25M | 37.33M | n/a | n/a | n/a | n/a | n/a | 40.00K | n/a |
| Other Investing Acitivies | 47.00K | 114.00K | 92.00K | -2.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -429.00K | 62.72M | 70.80M | -78.21M | -1.33M | -1.58M | -480.00K | -153.00K | -252.00K | -182.00K | -841.00K |
| Debt Repayment | -10.00M | -40.04M | -263.00K | -32.00K | -30.00K | 52.81M | 8.89M | n/a | 5.00M | 21.12M | 16.04M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -30.00K | 301.00K | 1.58M | 2.10M | 587.00K | 530.00K | 802.00K | 67.21M | 5.48M | n/a | n/a |
| Financial Cash Flow | 8.51M | -7.94M | 42.55M | 160.63M | 8.98M | 124.10M | 103.70M | 67.21M | 10.48M | 20.85M | 15.95M |
| Net Cash Flow | -19.85M | -24.13M | 5.12M | -8.28M | -85.07M | 68.41M | 69.12M | 39.71M | -4.86M | n/a | n/a |
| Free Cash Flow | -28.54M | -79.22M | -109.12M | -92.64M | -94.06M | -55.70M | -34.58M | -27.50M | -15.34M | -15.59M | -11.63M |